S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
S&P 500   3,376.29 (+1.28%)
DOW   27,896.34 (+0.76%)
QQQ   271.50 (+2.38%)
AAPL   449.76 (+2.80%)
MSFT   208.91 (+2.72%)
FB   260.71 (+1.79%)
GOOGL   1,505.20 (+1.67%)
AMZN   3,155.67 (+2.43%)
NVDA   454.73 (+4.78%)
CGC   17.40 (+2.65%)
BABA   255.51 (+2.85%)
TSLA   1,527.24 (+11.12%)
GE   6.61 (-1.78%)
MU   48.33 (+1.19%)
AMD   82.24 (+6.97%)
T   30.12 (-0.26%)
F   7.06 (-2.35%)
ACB   9.92 (-1.00%)
GILD   68.86 (+1.12%)
NFLX   479.79 (+2.75%)
DIS   130.63 (+0.11%)
BAC   26.47 (-1.67%)
BA   174.25 (-3.26%)
Log in

NASDAQ:UMRXUnum Therapeutics Earnings Date, Estimates & History

$2.29
-0.20 (-8.03 %)
(As of 08/12/2020 01:34 PM ET)
Add
Compare
Today's Range
$2.22
Now: $2.29
$2.38
50-Day Range
$0.43
MA: $2.15
$3.32
52-Week Range
$0.29
Now: $2.29
$3.72
Volume15,765 shs
Average Volume1.38 million shs
Market Capitalization$71.36 million
P/E RatioN/A
Dividend YieldN/A
Beta4.05

Earnings

Unum Therapeutics (NASDAQ:UMRX) Earnings Information

Unum Therapeutics last released its quarterly earnings results on August 11th, 2020. The reported ($0.24) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by $0.03. Unum Therapeutics has generated ($1.04) earnings per share over the last year. Unum Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 10th, 2020 based off prior year's report dates.

Unum Therapeutics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Unum Therapeutics (NASDAQ:UMRX) Earnings Estimates

2020 EPS Consensus Estimate: ($0.52)
2021 EPS Consensus Estimate: ($0.18)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.25)($0.25)($0.25)
Q2 20201($0.21)($0.21)($0.21)
Q3 20201($0.03)($0.03)($0.03)
Q4 20201($0.03)($0.03)($0.03)
Q1 20211($0.03)($0.03)($0.03)
Q2 20211($0.04)($0.04)($0.04)
Q3 20211($0.05)($0.05)($0.05)
Q4 20211($0.06)($0.06)($0.06)

Unum Therapeutics (NASDAQ UMRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/10/2020
(Estimated)
       
8/11/2020Q2 2020($0.21)($0.24)($0.24)N/A
5/11/20203/31/2020($0.30)($0.20)($0.20)$3.00 million$7.03 millionN/A
3/26/2020Q4 2019($0.26)$0.07$0.07$4.12 million$15.29 millionN/A
11/12/2019Q3($0.3250)($0.39)($0.39)$4.41 million$1.02 millionN/A
8/12/2019Q2 2019($0.39)($0.34)($0.34)$3.10 million$3.14 millionTranscript
5/13/20193/31/2019($0.31)($0.39)($0.39)$3.15 million$3.05 millionN/A
3/28/201912/31/2018($0.33)($0.29)($0.29)$2.58 million$3.80 millionN/A
11/12/20189/30/2018($0.35)($0.34)($0.34)$2.29 million$2.04 millionTranscript
8/13/2018Q2 2018($0.33)($0.31)($0.31)$2.45 million$1.67 millionN/A
5/14/2018Q1 2018($0.35)($0.66)($0.66)$2.45 million$2.22 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/12/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.